Skip to content
S6726Senate2011-2012 SessionSame asA7941

Requires facilities to perform pulse oximetry screening on newborns

Sponsor William J. Larkin Jr.SD-39Affects Health
Status
In Assembly Committee
Health
Impact
Pending
Passage
Pending

Bill progress

Step 5 of 7

In Assembly · Health

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

Primary sponsor
William J. Larkin Jr.

Senator · Senate District 39

No co-sponsors yet.

History

  1. Referred to health
  2. Delivered to assembly
  3. Passed senateVote 60–0
  4. Ordered to third reading cal.1381
  5. Committee discharged and committed to rules
  6. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A7941Assembly

Requires facilities to perform pulse oximetry screening on newborns

In Assembly Committee · Health · Sponsor Nancy Calhoun

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

BILL NUMBER:S6726

Title of bill

An act to amend the public health law, in relation to requiring facilities to perform pulse oximetry screening on newborns

Purpose

Requires facilities to perform pulse oximetry screening on newborns.

Justification

This bill requires each birthing facility in the state of New York be required to perform a pulse oximetry screening for congenital birth defects (CHDs), a minimum of 24 hours after birth, on every newborn in its care. For newborns, pulse oximetry screening involves taping a small sensor to a newborn's foot while the sensor beams red light through the foot to measure how much oxygen is in the blood, Pulse oximetry screening is effective at detecting CHDs that may otherwise go undetected by current screening methods. Pulse oximetry screenings are noninvasive, painless, and take approximately one minute to perform. According to the United States Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children, congenital heart disease affects approximately seven to nine of every 1,000 live births in the United States and Europe; the federal Centers for Disease Control and Prevention states that CHD is the leading cause of infant death due to birth defects. Current methods used to detect CHDs include prenatal ultrasound screening and repeated clinical examinations; however, prenatal ultrasound screenings, alone, identify less than half of all CHD cases. Many newborn lives could potentially be saved by requiring birthing facilities to incorporate pulse oximetry screening as a method for early detection of CHDs in conjunction with current CHD screening methods.

Fiscal implications

None to state.

Prior legislative history

New Bill.

Effective date

This act shall take effect on the one hundred eightieth day after it shall have become a law; provided, however, that effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.